180 related articles for article (PubMed ID: 21372249)
1. Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein.
de Laurentiis A; Gaspari M; Palmieri C; Falcone C; Iaccino E; Fiume G; Massa O; Masullo M; Tuccillo FM; Roveda L; Prati U; Fierro O; Cozzolino I; Troncone G; Tassone P; Scala G; Quinto I
Mol Cell Proteomics; 2011 May; 10(5):M111.007898. PubMed ID: 21372249
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated CD43 glycoforms as target of immunotherapy.
Tuccillo FM; Palmieri C; Fiume G; de Laurentiis A; Schiavone M; Falcone C; Iaccino E; Galandrini R; Capuano C; Santoni A; D'Armiento FP; Arra C; Barbieri A; Dal Piaz F; Venzon D; Bonelli P; Buonaguro FM; Scala I; Mallardo M; Quinto I; Scala G
Mol Cancer Ther; 2014 Mar; 13(3):752-62. PubMed ID: 24356816
[TBL] [Abstract][Full Text] [Related]
3. Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein.
de Laurentiis A; Caterino M; Orrù S; Ruoppolo M; Tuccillo F; Masullo M; Quinto I; Scala G; Pucci P; Palmieri C; Tassone P; Salvatore F; Venuta S
Int J Biol Macromol; 2006 Aug; 39(1-3):122-6. PubMed ID: 16580720
[TBL] [Abstract][Full Text] [Related]
4. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells.
Brown TJ; Shuford WW; Wang WC; Nadler SG; Bailey TS; Marquardt H; Mittler RS
J Biol Chem; 1996 Nov; 271(44):27686-95. PubMed ID: 8910360
[TBL] [Abstract][Full Text] [Related]
6. Detection of CD43 (leukosialin) in colon adenoma and adenocarcinoma by novel monoclonal antibodies against its intracellular domain.
Sikut R; Andersson CX; Sikut A; Fernandez-Rodriguez J; Karlsson NG; Hansson GC
Int J Cancer; 1999 Jul; 82(1):52-8. PubMed ID: 10360820
[TBL] [Abstract][Full Text] [Related]
7. Fetal ontogeny and tumor expression of the early thymic antigen UN1.
Tassone P; Tuccillo F; Bonelli P; D'Armiento FP; Bond HM; Palmieri C; Tagliaferri P; Venuta S
Int J Oncol; 2002 Apr; 20(4):707-11. PubMed ID: 11894113
[TBL] [Abstract][Full Text] [Related]
8. Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line.
Baeckström D; Zhang K; Asker N; Rüetschi U; Ek M; Hansson GC
J Biol Chem; 1995 Jun; 270(23):13688-92. PubMed ID: 7775421
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of a human sialoglycoprotein antigen expressed in immature thymocytes and fetal tissues.
Cecco L; Bond HM; Bonelli P; Tuccillo F; Cerra M; Tassone P; Sorice R; Lamberti A; Morrone G; Venuta S
Tissue Antigens; 1998 May; 51(5):528-35. PubMed ID: 9672151
[TBL] [Abstract][Full Text] [Related]
10. Production and the characterization of monoclonal antibody against CD43, K06.
Park WS; Chae JS; Jung KC; Choi WJ; Kook MC; Bae Y
Tissue Antigens; 2004 Jan; 63(1):46-53. PubMed ID: 14651523
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a 95 kDa human leucocyte sialoglycoprotein: its identity with CD43, gpL115, leukosialin and sialophorin.
Stefanová I; Hilgert I; Angelisová P; Kristofová H; Horejsí V
Folia Biol (Praha); 1988; 34(4):255-65. PubMed ID: 2467832
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of mucin-type O-glycosylation (MTOG) induced by peracetyl N-thioglycolyl-d-galactosamine (Ac
Dwivedi V; Saini P; Tasneem A; Agarwal K; Sampathkumar SG
Biochem Biophys Res Commun; 2018 Nov; 506(1):60-65. PubMed ID: 30336974
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Tn antigen on T-lymphoid cell line Jurkat.
Nakada H; Inoue M; Tanaka N; Numata Y; Kitagawa H; Fukui S; Yamashina I
Biochem Biophys Res Commun; 1991 Sep; 179(2):762-7. PubMed ID: 1716888
[TBL] [Abstract][Full Text] [Related]
14. CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target.
Fu Q; Cash SE; Andersen JJ; Kennedy CR; Oldenburg DG; Zander VB; Foley GR; Simon Shelley C
Int J Cancer; 2013 Apr; 132(8):1761-70. PubMed ID: 23015282
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis.
Hasegawa K; Tanaka S; Fujiki F; Morimoto S; Nakano K; Kinoshita H; Okumura A; Fujioka Y; Urakawa R; Nakajima H; Tatsumi N; Nakata J; Takashima S; Nishida S; Tsuboi A; Oka Y; Oji Y; Miyoshi E; Hirata T; Kumanogoh A; Sugiyama H; Hosen N
PLoS One; 2016; 11(3):e0152326. PubMed ID: 27011118
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of UN1, early thymocyte-associated sialoglycoprotein, in breast normal tissue, benign disease and carcinomas.
Tassone P; Bonelli P; Tuccillo F; Bond HM; D'Armiento FP; Galea E; Palmieri C; Tagliaferri P; Natali PG; Venuta S
Anticancer Res; 2002; 22(4):2333-40. PubMed ID: 12174923
[TBL] [Abstract][Full Text] [Related]
17. Signaling through CD43 regulates CD4 T-cell trafficking.
Mody PD; Cannon JL; Bandukwala HS; Blaine KM; Schilling AB; Swier K; Sperling AI
Blood; 2007 Oct; 110(8):2974-82. PubMed ID: 17638845
[TBL] [Abstract][Full Text] [Related]
18. Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death.
Hernandez JD; Nguyen JT; He J; Wang W; Ardman B; Green JM; Fukuda M; Baum LG
J Immunol; 2006 Oct; 177(8):5328-36. PubMed ID: 17015718
[TBL] [Abstract][Full Text] [Related]
19. A unique murine CD43 epitope Lp-3: distinct distribution from another CD43 epitope S7.
Shiota J; Nishimura H; Okamoto H; Yu B; Hattori S; Abe M; Okada T; Nozawa S; Tsurui H; Hirose S
Cell Immunol; 1994 May; 155(2):402-13. PubMed ID: 7514104
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte marker CD43 promotes cell growth in co-operation with β-catenin in non-hematopoietic cancer cells.
Balikova A; Jääger K; Viil J; Maimets T; Kadaja-Saarepuu L
Int J Oncol; 2012 Jul; 41(1):299-309. PubMed ID: 22576689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
